Trading Options with an Edge
Select Page

PTLA

Search by
TICKER SYMBOL

Portola Pharmaceuticals, Inc.

Sector: Health Technology
Industry: Pharmaceuticals: Other

18.03

0

(0%)

Volume:

0

52 week range:

5.31 - 31.73

Market Cap:

1.403B

Company Description:

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.